China Evergrande New Energy Vehicle Group (EVGRF) Fair Value & Analysis
Healthcare · US · Market cap $2.2M
Fair value as of: Jun 26, 2026
From 3 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $0.8000 to $0.0002 (−100.0%) since Jun 24, 2026.
Price vs Fair Value (12 months)
12‑month range $0.0002 – $0.0110 · the $0.0002 price screens below the $0.0002 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
China Evergrande New Energy Vehicle Group (EVGRF) currently trades at $0.0002, while our model-based Fair Value estimate is $0.0002 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 23/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Trailing-twelve-month revenue stands at $1.2B. Revenue declined 75.2% year over year. Net debt stands at $26.7B. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
China Evergrande New Energy Vehicle Group Limited, an investment holding company, engages in the technology research and development, manufacturing, sales, and servicing of new energy vehicles in the People's Republic of China and Europe. It operates through New Energy Vehicle and Property Development segments. The company is involved in the development and sale of vehicle living projects, and development and sale of properties. It also engages in design, manufacturing, and sale of power lithium batteries; sells vehicles and vehicle components; and technical services. The company was formerly known as Evergrande Health Industry Group Limited and changed its name to China Evergrande New Energy Vehicle Group Limited in August 2020. The company was founded in 1999 and is headquartered in Guangzhou, the People's Republic of China. China Evergrande New Energy Vehicle Group Limited operates as a subsidiary of China Evergrande Group.
Revenue & earnings trend
FY2019 – FY2023 · reported fiscal years
China Evergrande New Energy Vehicle Group reported revenue of $1.3B in FY2023 versus $6.4B in FY2019, a compound −32.3%/yr. Reported net income was −$11.9B in FY2023.
Is EVGRF fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FSNUY | $11.30 | $8.61 | -24% |
| Q0F Q0F | 2.76 SGD | 1.28 SGD | -54% |
| 5225 5225 | 8.70 MYR | 2.61 MYR | -70% |
| IHHHF IHHHF | $1.71 | $0.7400 | -57% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is China Evergrande New Energy Vehicle Group (EVGRF) undervalued?
What is the fair value of EVGRF?
What is the quality score of EVGRF?
What is the revenue of China Evergrande New Energy Vehicle Group (EVGRF)?
What is the net profit margin of EVGRF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.